Abuse Potential of Intravenous Remimazolam Compared to Midazolam and Placebo in Recreational CNS Depressant Users

Abuse, Drug Clinical Trial

Official title:
A Double-blind, Randomized Crossover Study to Assess the Subjective Abuse Potential of Intravenous Remimazolam Compared to Midazolam and Placebo in Recreational CNS Depressant Users

Status Completed

Clinical Trial Summary

A double-blind, randomized crossover study to assess the subjective abuse potential of intravenous remimazolam compared to midazolam and placebo in recreational CNS depressant users

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04110535
Study type	Interventional
Source	Paion UK Ltd.
Contact
Status	Completed
Phase	Phase 1
Start date	June 23, 2015
Completion date	October 6, 2015

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT05865470` - Age-dependent Effects of Smoked and Oral Delta-9-THC	Phase 1
Recruiting	`NCT04385082` - Cannabis Effects as a Function of Sex (CanSex)	Phase 1
Recruiting	`NCT04859296` - AnalgeSiC and appEtite-stimulating Effects of caNnabigerol and THC (ASCENT)	Phase 1
Recruiting	`NCT04451863` - Analgesic and Subjective Effects of Terpenes	Phase 1
Completed	`NCT03757559` - A Trial to Evaluate the Abuse Potential of 3 Doses of GRT6005 in Adult Non-dependent Recreational Opioid Users	Phase 1
Active, not recruiting	`NCT03679949` - Effects of Cannabis on Prescription Drug Abuse Liability and Analgesia	Phase 1